← Leaderboards
Stephen E. Braun
Harvard University (Medical School)
$3,037,465
Attributed
$3,037,465
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $672.4K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,037,465 · 14
By mechanism
P51$3,037,465 · 14
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Ronald C Desrosiers$52,941,615
- Andrew A Lackner$56,391,965
- Keith G. Mansfield$12,495,552
- R. Paul Johnson$56,310,063
- Zheng W Chen$26,721,709
Others in their field
Top investigators on “Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- David Heimbrook · Leidos Biomedical Research, Inc.$161,931,307
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,044,559
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$70,591,644
- Michelle M Le Beau · University Of Chicago$70,506,423
Research focus
Stem CellsBiotechnologyAnimal ColonyPrimatesResourcesInstitutionFundingAcquired Immunodeficiency SyndromeUnited States National Institutes Of HealthTransfection /Expression VectorHiv-1ViralResearch PersonnelGenesComputer Retrieval Of Information On Scientific Projects DatabaseGene TherapySourceGrantVectorReconstitutionPromotor (Genetics)NumbersCell LineNonhuman Primate
Grant awards (18)
STEM CELL GENE THERAPY FOR AIDS USING AN ANTI-SIV ENVELOPE ANTISENSE MOLECULE$52,050
P51 · FY2007 · RR · contact PI
EVALUATION OF INHIBITION OF SHIV REPLICATION BY SIRNA VECTORS$52,049
P51 · FY2007 · RR · contact PI
OPTIMIZATION OF ONCORETROVIRAL VECTORS ENCODING RNA DECOYS$52,049
P51 · FY2007 · RR · contact PI
STEM CELL GENE THERAPY FOR AIDS USING AN ANTI-HIV ENVELOPE ANTISENSE MOLECULE$134,807
P51 · FY2006 · RR · contact PI
EVALUATION OF INHIBITION OF SHIV REPLICATION BY SIRNA VECTORS$134,807
P51 · FY2006 · RR · contact PI
OPTIMIZATION OF ONCORETROVIRAL VECTORS ENCODING RNA DECOYS$134,807
P51 · FY2006 · RR · contact PI
STEM CELL GENE THERAPY FOR AIDS USING AN ANTI-HIV ENVELOPE ANTISENSE MOLECULE$168,102
P51 · FY2005 · RR
STEM CELL TRANSDUCTION BY LENTIVIRAL VECTORS$168,102
P51 · FY2005 · RR
OPTIMIZATION OF ONCORETROVIRAL VECTORS ENCODING RNA DECOYS$168,102
P51 · FY2005 · RR
EVALUATION OF INHIBITION OF SHIV REPLICATION BY SIRNA VECTORS$168,102
P51 · FY2005 · RR
STEM CELL TRANSDUCTION BY LENTIVIRAL VECTORS$204,218
P51 · FY2004 · RR
INHIBITION OF SHIV REPLICATION BY SIRNA VECTORS$204,218
P51 · FY2004 · RR
OPTIMIZATION OF ONCORETROVIRAL VECTORS ENCODING RNA$204,218
P51 · FY2004 · RR
STEM CELL GENE THERAPY FOR AIDS USING ANTI-HIV ENVELOPE$204,218
P51 · FY2004 · RR
STEM CELL TRANSDUCTION BY LENTIVIRAL VECTORS$246,904
P51 · FY2003 · RR
STEM CELL GENE THERAPY FOR AIDS USING AN ANTI-HIV ENVELOPE ANTISENSE MOLECULE$246,904
P51 · FY2003 · RR
EVALUATION OF INHIBITION OF SHIV REPLICATION BY SIRNA VECTORS$246,904
P51 · FY2003 · RR
OPTIMIZATION OF ONCORETROVIRAL VECTORS ENCODING RNA DECOYS$246,904
P51 · FY2003 · RR